Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen for Cerebral Oxygenation and Cognitive Function in One-Lung Ventilation
NCT07399184Not yet recruiting
- Sponsor
- Ondokuz Mayıs University
- Start
- Feb 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of ibuprofen in postoperative delirium (POD) and Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoint: Regional Cerebral Oxygen Saturation. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
ibuprofen
03
Conditions
postoperative delirium (POD)Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT07399184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07399184.